Axsome Therapeutics (AXSM) Other Non-Current Assets (2015 - 2022)

Axsome Therapeutics has reported Other Non-Current Assets for 8 years, with the latest figure at $507464.0 in Q2 2022.

• Quarterly Other Non-Current Assets rose 59.89% year-over-year to $507464.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $507464.0 (up 59.89% YoY) and the FY2021 annual result came in at $322910.0, up 1.74% from the prior year.
• Other Non-Current Assets advanced to $507464.0 in Q2 2022 per AXSM's latest filing, from $322910.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $507464.0 in Q2 2022 and troughed at $101516.0 in Q1 2019.
• A 5-year average of $226134.4 and a median of $168969.0 in 2019 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2018 and 2020: Other Non-Current Assets plunged 40.23% in 2018, then surged 126.9% in 2020.
• Over 5 years, Other Non-Current Assets stood at $112345.0 in 2018, then rose by 24.5% to $139875.0 in 2019, then soared by 126.9% to $317375.0 in 2020, then gained by 1.74% to $322910.0 in 2021, then surged by 57.15% to $507464.0 in 2022.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $507464.0, $322910.0, and $322910.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.